Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for at least a ...

Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...

U.S. District Judge Cynthia Rufe, of the Eastern District of Pennsylvania, gave the claims recovery firms seven days to provide lead counsel with a list of names and contact information for all class ...

ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...

TIOBE Programming Index News – November 2025: C# Closes In on Java Your email has been sent The November 2025 TIOBE Index brings another twist below Python’s familiar lead. C solidifies its position ...

Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a new plan on Wednesday that he said will drastically reduce drug prices in the U.S. He said the U.S. Food and Drug Administration is ...

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

Rollercoaster Tycoon wasn’t the most fashionable computer game out there in 1999. But if you took a look beneath the pixels—the rickety rides, the crowds of hungry, thirsty, barfing people (and the ...

AbbVie has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq by more than a decade. AbbVie on Thursday said it has settled ...

AbbVie ABBV0.53%increase; green up pointing triangle has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq well into the next decade ...